XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION
6 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
SEGMENT INFORMATION

10. SEGMENT INFORMATION

 

SFAS No. 131, “Disclosures About Segments of an Enterprise and Related Information,” requires that companies disclose segment data based on how management makes decisions about allocating resources to segments and measuring their performance. Currently, we conduct our businesses in three operating segments – Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. Our Land & Hospital and Other Services business units operate in the United States. Our Medical Device and Pharmaceutical business unit currently operates primarily in the United Kingdom. All remaining assets, primarily our corporate offices and investment portfolio, are located in the United States. The segment classified as Corporate includes corporate operating activities that support the executive offices, capital structure and costs of being a public registrant. These costs are not allocated to the operating segments when determining profit or loss. The following table reflects our segments as of September 30, 2018 and 2017 and for the three month periods then ended.

 

          MEDICAL                    
Six months ended   LAND &     DEVICE &     OTHER              
December 31, 2018   HOSPITALITY     PHARMA     SERVICES     CORPORATE     TOTAL  
                               
Operating revenues, gross and net   $ 24,509     $ 71,011     $ —     $ —     $ 95,520  
Operating income (loss)   $ (2,203 )   $ (84,761 )   $ (201 )   $ (233,663 )   $ (320,828 )
Interest expense   $ (7,737 )   $ —     $ —     $ (162,581 )   $ (170,318 )
Depreciation and amortization   $ 15,667     $ 45,484     $ —     $ —     $ 61,151  
Identifiable assets   $ 943,966     $ 1,117,450     $ —     $ 162,129     $ 2,223,545  

 

          MEDICAL                    
Six months ended   LAND &     DEVICE &     OTHER              
December 31, 2017   HOSPITALITY     PHARMA     SERVICES     CORPORATE     TOTAL  
                               
Operating revenues, gross   $ 33,935     $ 266,162     $ —     $ —     $ 300,097  
Operating revenues, net   $ 33,935     $ 160,195     $ —     $ —     $ 194,130  
Operating income (loss)   $ 9,232     $ (54,827)     $ (1,727)     $ (99,584)     $ (146,906)  
Interest expense   $ 7,529     $ (3)     $ —     $ 32,080     $ 39,606  
Depreciation and amortization   $ —     $ 44,332     $ —     $ —     $ 44,332  
Identifiable assets   $ 1,380,809     $ 264,326     $ 90     $ 756,791     $ 2,402,016  

 

          MEDICAL                    
Three months ended   LAND &     DEVICE &     OTHER              
December 31, 2018   HOSPITALITY     PHARMA     SERVICES     CORPORATE     TOTAL  
                               
Operating revenues, gross and net   $ 14,759     $ 34,093     $ —     $ —     $ 48,852  
Operating income (loss)   $ 3,285     $ (34,335 )   $ (21 )   $ (181,743 )   $ (212,814 )
Interest expense   $ 3,841     $ —     $ —     $ 83,324     $ 87,165  
Depreciation and amortization   $ 7,834     $ 22,568     $ —     $ —     $ 30,402  

 

          MEDICAL                    
Three months ended   LAND &     DEVICE &     OTHER              
December 31, 2017   HOSPITALITY     PHARMA     SERVICES     CORPORATE     TOTAL  
                               
Operating revenues, gross   $ 19,685     $ 212,519     $ —     $ —     $ 718,337  
Operating revenues, net   $ 19,685     $ 106,552     $ —     $ —     $ 156,714  
Operating income (loss)   $ 3,005     $ (37,220)     $ 17,891     $ (303,689)     $ (278,136)  
Interest expense   $ 3,729     $ (1)     $ —     $ 13,250     $ 13,250  
Depreciation and amortization   $ —     $ 17,590     $ —     $ —     $ 25,424